StockData

Agios Pharmaceuticals vs Eton Pharmaceuticals

AGIO and ETON side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How AGIO and ETON compare

Agios Pharmaceuticals and Eton Pharmaceuticals are about the same size, with market caps of $1.8B and $1.8B.

Agios Pharmaceuticals grew revenue faster over the last twelve months (141% versus 81.5% for Eton Pharmaceuticals).

Eton Pharmaceuticals keeps more of each dollar of sales as profit, with a net margin of 12.0% compared with −418% at Agios Pharmaceuticals.

Agios Pharmaceuticals scores higher on the StockData Score (12 against 10 for Eton Pharmaceuticals), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricAGIOETON
Size and price
Market cap$1.8B$1.8B
Share price$29.89$63.65
Change, 1 year−31.5%276%
Change, 5 years−18.0%1408%
Beta (5Y)1.54−0.44
Employees53944
StockData Score
Total score12 (better)10
Valuation score1 (better)0
Growth score33
Performance score24 (better)
Health score6 (better)3
Dividend score00
Valuation
P/E–163×
P/S18.1×17.2× (better)
P/B1.7× (better)39.1×
EV/EBITDA–87.3×
P/FCF–123×
FCF yield−20.5%0.81% (better)
Fair value$27.70$10.20
Margin of safety−7.9% (better)−524%
Growth
Revenue growth (TTM)141% (better)81.5%
Revenue growth, 5Y average–360%
Net income growth (TTM)−163%–
EPS growth (TTM)−163%–
Profitability
Gross margin92.0% (better)57.9%
Operating margin−467%15.4% (better)
Net margin−418%12.0% (better)
FCF margin−371%14.0% (better)
Return on equity−34.3%36.0% (better)
Return on invested capital−759%42.5% (better)
Financial health
Debt / equity0.000.60 (better)
Net debt / EBITDA–0.05
Interest coverage–3.6×
Current ratio10.22 (better)1.52
Altman Z-score11.4516.19 (better)
Piotroski F-score14 (better)
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions111%74.0%
Held by insiders1.1%5.6%
Insider net buying, 12 months−$4.9M (better)−$35.0M
Short interest, % of float11.1%7.4%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.